|
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 51.79 | ACUITE BBB | Reaffirmed & Withdrawn | - |
Bank Loan Ratings | 0.02 | Not Applicable | Withdrawn | - |
Bank Loan Ratings | 6.00 | - | ACUITE A3+ | Reaffirmed & Withdrawn |
Total Outstanding | 0.00 | - | - |
Total Withdrawn | 57.81 | - | - |
Rating Rationale |
Acuité has reaffirmed and withdrawn the long-term rating of ‘ACUITE BBB’ (read as ACUITE triple B) and the short-term rating of 'ACUITE A3+' (read as ACUITE A three plus) on the Rs 57.79 crore bank facilities of Ivis International Private Limited (IIPL). Acuité has also withdrawn the long-term rating on the Rs.0.02 crore bank Facilities of Ivis International Private Limited (IIPL). The same is withdrawn without assigning any rating as it is a proposed facility. The withdrawal is in accordance with Acuite's policy on withdrawal of ratings as applicable to the respective facility / instrument. The rating is being withdrawn on account of request received from the company, and NOC (No Objection Certificate) received from the banker. |
About Company |
Incorporated in October 2014 in Telangana, Ivis International Private Limited is engaged in providing video monitoring services to banks & financial institutions for ATMs, retail outlets, warehouses and government institutions. Ivis is a part of the larger Provigil Group (defined later in the document) which is also engaged in similar line of business. Further, the company also sells the video monitoring equipment to its customers, depending upon the nature of the order. Mr. Prabhakara Rao Bollina, Mr. Rachapoodi Venkata Nagendra Murali Mohan, Mr. Ameeruddin Syed and Mr. Joseph Sudheer Reddy Thumma are the directors of the company. |
About the Group |
Ivis International Private Limited and Provigil Surveillance Limited are together referred to as Provigil Group. Since 2007, Provigil was initially engaged in the business of providing technology and back-end monitoring operations to US-based Provigil Inc. which was incorporated in 2006. However, Provigil Inc. has now been bought by a US-based private equity firm and looks after the US operations, whereas Provigil has been retained by the current management to look after the Indian operations. Currently, Ivis and Provigil are engaged providing video monitoring services to banks & financial institutions for ATMs, retail outlets, warehouses and government institutions. Further, both the companies also sell the video monitoring equipment to its customers, depending upon the nature of the order. Since Provigil as a brand has more experience in the market, most of the orders are currently routed through Provigil, although Ivis executes those orders. |
Unsupported Rating |
Not Applicable |
Analytical Approach |
Extent of Consolidation |
•Full Consolidation |
Rationale for Consolidation or Parent / Group / Govt. Support |
Acuité has consolidated the business and financial risk profiles of Ivis International Private Limited and Provigil Surveillance Limited to arrive at the rating. The consolidation is in the view of the similarities in the lines of business, operational & financial synergies and common management. |
Key Rating Drivers |
Strengths |
Experienced management and long track record of operation Healthy financial risk profile |
Weaknesses |
Working capital intensive nature of operations |
Rating Sensitivities |
Not Applicable |
Liquidity Position |
Adequate |
The Group generated healthy net cash accruals worth Rs. 46.17 Cr. and Rs. 44.37 Cr. in FY2023 and FY2022 respectively as against moderate debt repayment obligations Rs. 9.98 Cr. and Rs. 8.66 Cr. in those respective years. Furthermore, the current ratio stood healthy at 2.19 times as on March 31, 2023 as against 2.24 times as on March 31, 2022. The working capital requirements are majorly funded by way of internal accruals, whereas the average CC utilization in the last 12 months ended December 2023 stood moderately at 53.19% for the group. The cash and bank balance of the group is Rs.42.07 Cr. as on March 31 2023. |
Outlook: |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 23 (Actual) | FY 22 (Actual) |
Operating Income | Rs. Cr. | 137.05 | 132.25 |
PAT | Rs. Cr. | 27.81 | 26.73 |
PAT Margin | (%) | 20.29 | 20.21 |
Total Debt/Tangible Net Worth | Times | 0.77 | 0.41 |
PBDIT/Interest | Times | 11.89 | 12.53 |
Status of non-cooperation with previous CRA (if applicable) |
Not Applicable |
Any Other Information |
None |
Applicable Criteria |
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm • Consolidation Of Companies: https://www.acuite.in/view-rating-criteria-60.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Service Sector: https://www.acuite.in/view-rating-criteria-50.htm |
Note on Complexity Levels of the Rated Instrument |
In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in. |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
*Annexure 2 - List of Entities (applicable for Consolidation or Parent / Group / Govt. Support) |
1. Ivis International Private Limited |
Contacts |
|
|
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |